Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2025-12-31 @ 11:58 AM
Study NCT ID:
NCT01296932
Status:
COMPLETED
Last Update Posted:
2020-08-20
First Post:
2011-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02-11
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-07-10
Completion Date Type:
ACTUAL
First Submit Date:
2011-02-15
First Submit QC Date:
None
Study First Post Date:
2011-02-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-12-11
Results First Submit QC Date:
None
Results First Post Date:
2020-08-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-10
Last Update Post Date:
2020-08-20
Last Update Post Date Type:
ACTUAL